back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-09-29 17:38 Tx date 2023-09-22 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-1,051,249 vol |
1,859,964 | |
| Filed 2022-10-28 17:51 Tx date 2022-10-27 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$900.00
+5,000 vol $0.18 each |
135,000 | |
| Filed 2022-10-21 17:27 Tx date 2022-10-21 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$330.00
+1,500 vol $0.22 each |
130,000 | |
| Filed 2022-10-19 18:25 Tx date 2022-10-19 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,000
+5,000 vol $0.20 each |
128,500 | |
| Filed 2022-10-05 12:09 Tx date 2022-10-03 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,200
+5,000 vol $0.24 each |
123,500 | |
| Filed 2022-09-09 17:07 Tx date 2022-09-09 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$110.00
+500 vol $0.22 each |
118,500 | |
| Filed 2022-09-09 17:07 Tx date 2022-09-08 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$330.00
+1,500 vol $0.22 each |
118,000 | |
| Filed 2022-08-29 16:39 Tx date 2022-08-26 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$650.00
+2,500 vol $0.26 each |
115,000 | |
| Filed 2022-08-29 16:39 Tx date 2022-08-26 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$550.00
+2,500 vol $0.22 each |
112,500 | |
| Filed 2022-08-29 16:38 Tx date 2022-08-26 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$375.00
+1,500 vol $0.25 each |
116,500 | |
| Filed 2022-08-29 16:37 Tx date 2022-08-26 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$400.00
+2,500 vol $0.16 each |
||
| Filed 2022-08-29 16:37 Tx date 2022-08-26 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$300.00
+2,500 vol $0.12 each |
||
| Filed 2022-03-29 12:28 Tx date 2022-03-29 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$79,200
+110,000 vol $0.72 each |
110,000 | |
| Filed 2022-03-29 12:27 Tx date 2022-03-21 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-29 12:26 Tx date 2022-03-29 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$66,000
+110,000 vol $0.60 each |
110,000 | |
| Filed 2022-03-29 11:37 Tx date 2022-03-21 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-24 14:26 Tx date 2021-09-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$888.00
+300 vol $2.96 each |
21,228 | |
| Filed 2021-09-24 14:26 Tx date 2021-09-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,008
+3,033 vol $2.97 each |
20,928 | |
| Filed 2021-09-07 11:10 Tx date 2021-08-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,850
+5,000 vol $2.77 each |
17,895 | |
| Filed 2021-08-23 10:43 Tx date 2021-08-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,385
+500 vol $2.77 each |
||
| Filed 2021-08-23 10:43 Tx date 2021-08-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,385
+500 vol $2.77 each |
13,395 | |
| Filed 2021-06-22 14:47 Tx date 2021-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,061
+300 vol $6.87 each |
12,895 | |
| Filed 2021-06-22 14:46 Tx date 2021-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,085
+300 vol $6.95 each |
12,595 | |
| Filed 2021-06-22 14:46 Tx date 2021-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,408
+200 vol $7.04 each |
12,295 | |
| Filed 2021-06-22 14:46 Tx date 2021-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,600
+500 vol $7.20 each |
12,095 | |
| Filed 2021-06-22 14:45 Tx date 2021-06-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,000
+1,200 vol $7.50 each |
18,132 | |
| Filed 2020-05-29 13:42 Tx date 2020-05-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$-17,152.80
-6,126 vol $2.80 each |
11,595 | |
| Filed 2020-05-29 13:41 Tx date 2020-05-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$17,152
+6,126 vol $2.80 each |
7,571 | |
| Filed 2019-03-08 Tx date 2013-12-10 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-03-08 Tx date 2019-03-01 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$25,999
+6,265 vol $4.15 each |
16,932 | |
| Filed 2019-03-08 Tx date 2019-03-08 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$-31,996.50
-7,710 vol $4.15 each |
17,721 | |
| Filed 2019-03-08 Tx date 2019-03-08 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$5,996
+1,445 vol $4.15 each |
1,445 | |
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+214,000 vol |
||
| Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+214,000 vol |
214,000 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+214,000 vol |
214,000 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-149,333 vol |
10,667 | |
| Filed 2018-12-21 Tx date 2013-12-10 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-774,667 vol |
55,333 | |
| Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-356,027 vol |
25,431 | |
| Filed 2018-10-26 Tx date 2018-10-26 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$-30,000
-100,000 vol $0.30 each |
381,458 | |
| Filed 2018-10-26 Tx date 2018-10-26 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$30,000
+100,000 vol $0.30 each |
160,000 | |
| Filed 2018-10-24 Tx date 2018-10-23 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$18,300
+60,000 vol $0.305 each |
60,000 | |
| Filed 2018-10-24 Tx date 2018-10-23 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$-18,300
-60,000 vol $0.305 each |
481,458 | |
| Filed 2018-10-24 Tx date 2013-12-10 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-10 Tx date 2018-01-08 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,700
+10,000 vol $0.27 each |
531,458 | |
| Filed 2018-01-10 Tx date 2018-01-09 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,750
+10,000 vol $0.275 each |
541,458 | |
| Filed 2017-09-06 Tx date 2017-09-01 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$15,000
+60,000 vol $0.25 each |
521,458 | |
| Filed 2017-07-28 Tx date 2017-07-27 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+100,000 vol $0.30 each |
830,000 | |
| Filed 2016-08-18 Tx date 2016-08-18 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$8,499
+28,333 vol $0.30 each |
461,458 | |
| Filed 2016-07-27 Tx date 2016-07-25 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+250,000 vol $0.30 each |
730,000 | |
| Filed 2016-05-24 Tx date 2016-05-20 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,750
+50,000 vol $0.175 each |
433,125 | |
| Filed 2015-07-28 Tx date 2015-07-23 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$102,000
+300,000 vol $0.34 each |
480,000 | |
| Filed 2014-01-24 Tx date 2014-01-22 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,800
+180,000 vol $0.46 each |
180,000 | |
| Filed 2014-01-24 Tx date 2013-12-10 |
$PDP
Pediapharm Inc. |
Boivin, Roland
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|